Catalyst Wire Dossier Catalyst Wire Dossier

AREDS2 supplement formulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AREDS2 supplement formulation, covering 2013-12-24 to 2013-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Age-Related Eye Disease Study 2 (AREDS2) [Phase 3]

See pricing